Attendee search 

RIEMSER Pharma GmbH is a European specialty pharmaceutical company established in December 1992 with core competencies focused niche therapy areas with high unmet medical need.

RIEMSER markets its own product portfolio in numerous therapeutic areas including oncology, neurology, anti-infectives and dermatology.

RIEMSER is present with own affiliates in Germany, France and UK and is selling its products in > 60 countries worldwide through a network of trusted partners.

We are looking to strengthen our portfolio through licensing or acquisition.

Krewel Meuselbach (KM) is a medium-sized Company of German origin. Beside the German Organisation, KM is historically strong in particular in Russia/CIS countries as well as Slovakia and Poland with own organisations.

Today KM is strategically focused on OTC-products with a strong competence in phyto-pharmaceutical drugs. Inhouse R&D and innovative pharmaceutical processing results in differentiated products with clear USP’s (e.g. free of alcohol and preservatives, standardized high bioavailability).

Strathos Pharma is a privately owned company group which is active within the following business fields:

Marketing and distribution of OTC brands in Germany, Switzerland and Austria with specific strengths

in the field of: Cough & Cold, Sinus, Respiratory and Allergy products (Siemens & CO: Emser®); herbal

(medicinal) teas and herbal products (Sidroga®) both in pharmacies and drug stores (Emsan®).

The company group´s annual turnover exceeds 55 Mio. EUR.

Strong sales and marketing structures in our target markets (Germany, Switzerland and Austria) with 50

sales representatives and about 8.000 permanent product displays (shop in shop system) in pharmacies

and key acount Management of Drugstores.

In-Licensing of products for extension of our OTC portfolio in Germany, Switzerland and Austria.

Main target areas for natural products (e.g. phyto medicine): Cough & Cold, Sinus, Respiratory, Allergy,

Sleep disorders, Mental Stress, CNS, Female Health, Male Health, Gastro - all regulatory pathways

(medicinal products, medical device, etc.)

Additionally substance based medical devices for all indications

Advanced development projects in the upper mentioned therapeutic categories - generic and innovative.

Helm AG is a Hamburg- based, privately owned company and represented by own subsidiaries in more

than 30 countries worldwide.

In cooperation with highly acclaimed international partners, Helm offers developments of generic

pharmaceuticals, IP researches, registrations of high quality e-CTD dossiers, launch and life cycle

management.

Our global presence and extensive variety of excellent service functions mean that Helm is your ideal

partner for all stages of the product life cycle from the initial idea generation through to the launch and

supply of the medicinal product.

We offer:

-High quality e-CTD dossiers per current EU-requirements and international registration strategies.

-Tailor made portfolio ideas.

- Excellent project management

- Collaborations for innovative technology platforms.

We are interested in:

- Identifying out-licensing and co-operation opportunities - especially for EU, Nordics, UK, LATAM, MENA

& CIS markets.

- Exploring product & brand acquisition opportunities in the targeted territories.

- Divestment of companies

We are NOT interested in:

- Regulatory Services

- CRO + CMO Services